JP2009523732A5 - - Google Patents

Download PDF

Info

Publication number
JP2009523732A5
JP2009523732A5 JP2008550455A JP2008550455A JP2009523732A5 JP 2009523732 A5 JP2009523732 A5 JP 2009523732A5 JP 2008550455 A JP2008550455 A JP 2008550455A JP 2008550455 A JP2008550455 A JP 2008550455A JP 2009523732 A5 JP2009523732 A5 JP 2009523732A5
Authority
JP
Japan
Prior art keywords
alkyl
optionally substituted
defined above
aryl
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008550455A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009523732A (ja
Filing date
Publication date
Priority claimed from US11/331,180 external-priority patent/US7868037B2/en
Application filed filed Critical
Priority claimed from PCT/US2007/000996 external-priority patent/WO2007084435A2/en
Publication of JP2009523732A publication Critical patent/JP2009523732A/ja
Publication of JP2009523732A5 publication Critical patent/JP2009523732A5/ja
Withdrawn legal-status Critical Current

Links

JP2008550455A 2006-01-13 2007-01-16 C型肝炎の治療方法 Withdrawn JP2009523732A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US75852706P 2006-01-13 2006-01-13
US11/331,180 US7868037B2 (en) 2004-07-14 2006-01-13 Methods for treating hepatitis C
US92148307P 2007-01-13 2007-01-13
PCT/US2007/000996 WO2007084435A2 (en) 2006-01-13 2007-01-16 Methods for treating hepatitis c

Publications (2)

Publication Number Publication Date
JP2009523732A JP2009523732A (ja) 2009-06-25
JP2009523732A5 true JP2009523732A5 (zh) 2010-03-04

Family

ID=38283923

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008550455A Withdrawn JP2009523732A (ja) 2006-01-13 2007-01-16 C型肝炎の治療方法

Country Status (2)

Country Link
JP (1) JP2009523732A (zh)
WO (1) WO2007084435A2 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE543808T1 (de) 2006-12-22 2012-02-15 Schering Corp 5,6-ring-annelierte indolderivate und ihre verwendung
AU2007339386B8 (en) 2006-12-22 2013-12-05 Merck Sharp & Dohme Corp. 4, 5-ring annulated indole derivatives for treating or preventing of HCV and related viral infections
BRPI0720625A2 (pt) 2006-12-22 2014-03-25 Schering Corp Derivados de indol de 4,5-anel anulados e métodos de uso dos mesmos
EP2408761B1 (en) 2007-08-29 2014-01-01 Merck Sharp & Dohme Corp. Substituted indole derivatives and methods of use thereof
CN101842353A (zh) 2007-08-29 2010-09-22 先灵公司 用于治疗病毒感染的2,3-取代的吲哚衍生物
CA2697500A1 (en) * 2007-08-29 2009-03-12 Schering Corporation 2,3-substituted azaindole derivatives for treating viral infections
CA2705586A1 (en) 2007-11-16 2009-05-22 Schering Corporation 3-heterocyclic substituted indole derivatives and methods of use thereof
CA2705587A1 (en) 2007-11-16 2009-05-22 Schering Corporation 3-aminosulfonyl substituted indole derivatives and methods of use thereof
AR072088A1 (es) 2008-06-13 2010-08-04 Schering Corp Derivados de indol triciclicos y sus metodos de uso
TWI438200B (zh) * 2009-02-17 2014-05-21 必治妥美雅史谷比公司 C型肝炎病毒抑制劑
EP2545050B1 (en) * 2010-03-10 2014-08-13 Bristol-Myers Squibb Company Compounds for the treatment of hepatitis c
EP3188730B1 (en) 2014-09-05 2019-05-01 Merck Sharp & Dohme Corp. Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2
EP3188732B1 (en) 2014-09-05 2019-07-24 Merck Sharp & Dohme Corp. Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2
EP3188731B1 (en) 2014-09-05 2019-04-03 Merck Sharp & Dohme Corp. Isoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2
JP2020502058A (ja) 2016-11-18 2020-01-23 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. ジアシルグリセリドo−アシルトランスフェラーゼ2の阻害薬として有用なインダゾール誘導体
MA46859A (fr) 2016-11-18 2019-09-25 Merck Sharp & Dohme Dérivés d'indole utiles en tant qu'inhibiteurs de la diacylglycéride o-acyltransférase 2
RS65335B1 (sr) 2018-10-05 2024-04-30 Annapurna Bio Inc Jedinjenja i kompozicije za lečenje stanja povezanih sa aktivnošću receptora apj

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2335700A1 (en) * 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
US20050215614A1 (en) * 2002-10-15 2005-09-29 Rigel Pharmaceuticals, Inc. Substituted indoles and their use as hcv inhibitors
US7098231B2 (en) * 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) * 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
GB0323845D0 (en) * 2003-10-10 2003-11-12 Angeletti P Ist Richerche Bio Chemical compounds,compositions and uses
JP2008506702A (ja) * 2004-07-14 2008-03-06 ピーティーシー セラピューティクス,インコーポレーテッド C型肝炎を治療するための方法

Similar Documents

Publication Publication Date Title
JP2009523732A5 (zh)
AR113903A2 (es) Derivados fungicidas de pirazol carboxamidas
JP2013531029A5 (zh)
AR067946A1 (es) Imidazoles biciclicos fusionados
RU2016125306A (ru) Новые пестицидные соединения и применения
RU2015131149A (ru) N-(замещенные)-5-фтор-4-имино-3-метил-2-оксо-3,4-дигидропиримидин-1(2н)-карбоксамидные производные
PE20181304A1 (es) Derivados de indol n-sustituidos como moduladores de los receptores de pge2
PE20141075A1 (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas que contienen un grupo sulfoximina
EA201791254A1 (ru) Кристаллические сольваты и комплексы производных (1s)-1,5-ангидро-1-c-(3-((фенил)метил)фенил)-d-глюцитола с аминокислотами в качестве ингибиторов sglt2 для лечения диабета
JP2011524422A5 (zh)
RU2010126105A (ru) Производные пиридина, замещенные гетероциклическим кольцом и фосфоноксиметильной группой, и содержащие их противогрибковые средства
AR094929A1 (es) Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
AR087288A1 (es) Compuestos de tetrahidropirido-piridina y tetrahidropirido-pirimidina y su uso como moduladores de receptores de c5a
RU2010106393A (ru) Новые микробиоциды
AR057062A1 (es) Moduladores de aminoquinolina y aminoquinazolina quinasa
RU2015131095A (ru) Производные n-(замещенного)-5-фтор-4-имино-3-метил-2-оксо-3,4-дигидропиримидин-1(2н)-карбоксилата
RU2011116160A (ru) Производные пиридина, замещенные гетероциклическим кольцом и y-глутамиламиногруппой и содержащие их противогрибковые средства
CA2539349A1 (en) 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
EA022420B1 (ru) Гетероциклические ингибиторы глутаминилциклазы (qc, ec 2.3.2.5)
RU2010101004A (ru) Новые микробиоциды
RU2016118399A (ru) Производные 4-аминометилбензойной кислоты
CA2626402A1 (en) Potassium channel inhibitors
EA201490722A1 (ru) ПРОИЗВОДНЫЕ ЭТИНИЛА В КАЧЕСТВЕ АЛЛОСТЕРИЧЕСКИХ МОДУЛЯТОРОВ МЕТАБОТРОПНОГО РЕЦЕПТОРА ГЛУТАМАТА mGluR5
AR078783A1 (es) Compuestos heterociclicos pesticidas
AR077819A1 (es) Compuestos heterociclicos antagonistas de esfingosina -1-fosfato (sip)